CapsoVision to Participate in Upcoming Investor Conferences

SARATOGA, Calif., Sept. 03, 2026 /CourierPR/ -- CapsoVision, a commercial-stage medical technology company specializing in advanced imaging and AI-enabled capsule endoscopy solutions, is set to participate in two upcoming investor conferences in New York City.

At the H.C. Wainwright 28th Annual Global Investment Conference, which runs from September 14 to 16, CapsoVision's leadership team will present and conduct one-on-one meetings. The company will provide an on-demand presentation on September 11, 2026, starting at 7:00 am Eastern Time. Interested investors can schedule individual meetings with the company's management during the conference.

Additionally, CapsoVision will attend the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, where it will offer one-on-one investor meetings.

CapsoVision's flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope capable of high-resolution visualization of the small bowel, with support for cloud-based or direct capsule video retrieval. The company is also developing CapsoCam Colon™, an AI-enhanced product designed for non-invasive colon imaging and polyp detection.

With a proprietary platform targeting multiple gastrointestinal indications, including esophageal and pancreatic disorders, CapsoVision aims to revolutionize capsule-based diagnostics. The company's website, www.capsovision.com, offers more information about its products and initiatives.